Cargando…

APOA-I: A Possible Novel Biomarker for Metabolic Side Effects in First Episode Schizophrenia

The purpose of this study was to investigate the change in plasma protein expression in first episode schizophrenia after an 8-week treatment with risperidone, and to explore potential biomarkers for metabolic side effects associated with risperidone treatment. Eighty first-episode schizophrenia pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Xueqin, Li, Xue, Gao, Jinsong, Zhao, Jingping, Li, Youhui, Fan, Xiaoduo, Lv, Luxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978061/ https://www.ncbi.nlm.nih.gov/pubmed/24710015 http://dx.doi.org/10.1371/journal.pone.0093902

Ejemplares similares

Decreased Functional Connectivity of Insular Cortex in Drug Naïve First Episode Schizophrenia: In Relation to Symptom Severity
por: Pang, Lijuan, et al.
Publicado: (2017)

Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia
por: Song, Xueqin, et al.
Publicado: (2014)

Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study
por: Yuan, Xiuxia, et al.
Publicado: (2021)

The Role of Butyric Acid in Treatment Response in Drug-Naïve First Episode Schizophrenia
por: Li, Xue, et al.
Publicado: (2021)

Decreased Resting-State Interhemispheric Functional Connectivity Correlated with Neurocognitive Deficits in Drug-Naive First-Episode Adolescent-Onset Schizophrenia
por: Liu, Yi, et al.
Publicado: (2017)

Reduced Brain Activity in the Right Putamen as an Early Predictor for Treatment Response in Drug-Naive, First-Episode Schizophrenia
por: Wu, Renrong, et al.
Publicado: (2019)

Disrupted asymmetry of inter- and intra-hemispheric functional connectivity in patients with drug-naive, first-episode schizophrenia and their unaffected siblings
por: Zhu, Furong, et al.
Publicado: (2018)

Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia
por: Li, Zongchang, et al.
Publicado: (2015)

Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine
por: Ma, Jun, et al.
Publicado: (2021)

N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients
por: Zong, Xiaofen, et al.
Publicado: (2015)

Abnormal functional connectivity of the striatum in first‐episode drug‐naive early‐onset Schizophrenia
por: Zhang, Yan, et al.
Publicado: (2022)

Abnormal patterns of regional homogeneity and functional connectivity across the adolescent first-episode, adult first-episode and adult chronic schizophrenia
por: Yang, Yongfeng, et al.
Publicado: (2022)

Insulin Resistance and Oxidative Stress: In Relation to Cognitive Function and Psychopathology in Drug-Naïve, First-Episode Drug-Free Schizophrenia
por: Tao, Qi, et al.
Publicado: (2020)

The Variants at APOA1 and APOA4 Contribute to the Susceptibility of Schizophrenia With Inhibiting mRNA Expression in Peripheral Blood Leukocytes
por: Fan, Yao, et al.
Publicado: (2021)

Enhanced baseline activity in the left ventromedial putamen predicts individual treatment response in drug-naive, first-episode schizophrenia: Results from two independent study samples
por: Li, Huabing, et al.
Publicado: (2019)

Microglia activation in the offspring of prenatal Poly I: C exposed rats: a PET imaging and immunohistochemistry study
por: Li, Xue, et al.
Publicado: (2018)

Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
por: Joubert, Francois-Pierre, et al.
Publicado: (2021)

Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
por: Zhang, Yan, et al.
Publicado: (2021)

Erratum: Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
por: Joubert, Francois-Pierre, et al.
Publicado: (2021)

Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer
por: Shi, Feiyu, et al.
Publicado: (2018)

Abnormal resting-state brain activities in patients with first-episode obsessive-compulsive disorder
por: Niu, Qihui, et al.
Publicado: (2017)

Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping
por: Xu, Man, et al.
Publicado: (2021)

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
por: Cheng, Zhang, et al.
Publicado: (2020)

Cortical Pathways or Mechanism in the Face Inversion Effect in Patients with First-Episode Schizophrenia
por: Liu, Yi, et al.
Publicado: (2021)

Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients
por: Li, Zongchang, et al.
Publicado: (2023)

Striatum-related spontaneous coactivation patterns predict treatment response on positive symptoms of drug-naive first-episode schizophrenia with risperidone monotherapy
por: Zong, Xiaofen, et al.
Publicado: (2023)

Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia
por: Cao, Yin, et al.
Publicado: (2023)

Family-based case-control study of homotopic connectivity in first-episode, drug-naive schizophrenia at rest
por: Guo, Wenbin, et al.
Publicado: (2017)

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
por: Lebherz, Corinna, et al.
Publicado: (2007)

DNA Methylation Basis in the Effect of White Matter Integrity Deficits on Cognitive Impairments and Psychopathological Symptoms in Drug-Naive First-Episode Schizophrenia
por: Zong, Xiaofen, et al.
Publicado: (2021)

The nuclear factor-κB inhibitor pyrrolidine dithiocarbamate reduces polyinosinic-polycytidilic acid-induced immune response in pregnant rats and the behavioral defects of their adult offspring
por: Song, Xueqin, et al.
Publicado: (2011)

Treatment Response in First-episode Schizophrenia
por: Schennach, Rebecca, et al.
Publicado: (2012)

The neurobiology and treatment of first-episode schizophrenia
por: Kahn, R S, et al.
Publicado: (2015)

Dysexecutive Behavior in First-Episode Schizophrenia
por: Orellana, Gricel, et al.
Publicado: (2022)

Peripheral Biomarkers for First-Episode Psychosis—Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia
por: Trovão, Nuno, et al.
Publicado: (2019)

Hippocampal Subfield Volumes Predict Disengagement from Maintenance Treatment in First Episode Schizophrenia
por: Qi, Wei, et al.
Publicado: (2022)

Association Between ApoA1 Gene Polymorphisms and Antipsychotic Drug-Induced Dyslipidemia in Schizophrenia
por: Fan, Lin, et al.
Publicado: (2021)

Abnormal interhemispheric and intrahemispheric functional connectivity dynamics in drug‐naïve first‐episode schizophrenia patients with auditory verbal hallucinations
por: Wei, Yarui, et al.
Publicado: (2022)

Face and object visual working memory deficits in first-episode schizophrenia correlate with multiple neurocognitive performances
por: Liu, Yi, et al.
Publicado: (2021)

The unsolved mystery of apoA-I recycling in adipocyte
por: Wang, Shuai, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fj7aavfhn7l3itl226qljpk284